Latest News about BAYRY
Recent news which mentions BAYRY
From Benzinga
AstraZeneca's Imfinzi/Imjudo Combo Shows Sustained Overall Survival Benefit At Four Years In Liver Cancer
June 29, 2023
From Benzinga
Bayers Says Neuronal Stem Cell Therapy For Parkinson's Shows Encouraging Action In Early-Stage Study
June 28, 2023
From Benzinga
Experimental Stem Cell Therapy For Parkinson's Shows Promise in Phase I Trial: Reuters
June 28, 2023
From Benzinga
From Benzinga
From Benzinga
Perrigo Picks Former Bayer Executive As New CEO
June 08, 2023
From Benzinga
From InvestorPlace
Johnson & Johnson Unleashes Kenvue: Tylenol to Neutrogena, $40B Revenue Unit Spinoff Preps for IPO Blitz
April 24, 2023
From Benzinga
From Benzinga
From Benzinga
Bayer Seeks To Double US Revenues Over Next Decade, With Planned R&D Spending Of Around $1B
March 10, 2023
From Benzinga
EXCLUSIVE: How To Lower The Cost Of Cannabis Quality And Save 30% Of Your Top-Line Revenue
February 15, 2023
From Benzinga
Bayer Bolsters Its Position In Digital Medical Imaging With Acquisition Of UK-Based Firm
January 18, 2023
From Benzinga
FAA Technology Glitch Hits US Flights Operations, Coca-Cola & PepsiCo Under FTC Probe, Rivian Hit By Mass Executive Exodus: Today's Top Stories
January 11, 2023
From Benzinga
Activist Investor Builds Stake In Bayer, Pushes Breakup
January 11, 2023
From Benzinga
Key Marijuana Executive Changes: Who Will Lead MariMed After CEO's Passing? MJBiz CEO Steps Down
December 19, 2022
From Benzinga
Ionis Regains Rights To Thrombosis Candidate From Bayer
November 04, 2022
From Benzinga
From InvestorPlace
What Is Going on With AVEO Pharmaceuticals (AVEO) Stock Today?
October 18, 2022
From InvestorPlace
From Benzinga
Roundup Weedkiller Maker Bayer Won Five Consecutive Cases, Shifting Momentum In Bayer's Favor
October 05, 2022
From Benzinga
7 Under-$20 Sleeper Stocks to Buy Before Wall Street Wakes Up
September 27, 2022
From InvestorPlace
Top Financial Stories Wednesday, September 14: Multiple Antitrust Setbacks For Google, Bitcoin Crashes, Visa Finds New Gun Control System Ineffective And More...
September 14, 2022
From Benzinga
After Investor Flak, German Healthcare Giant Bayer Starts Hunt For New CEO: Report
September 14, 2022
From Benzinga
BeiGene's Tislelizumab Shows Non-Inferiority In Overall Survival, Safety Vs Standard Treatment In Solid Tumors
September 12, 2022
From Benzinga
Deere Invests Billions In Self-Driving Tractors, Smart Crop Sprayers: Report
September 12, 2022
From Benzinga
Regeneron Gains As New Data Favors Higher Dose Of Flagship Eye Disease Drug
September 08, 2022
From Benzinga
7 Stocks Under $15 to Buy and Hold Forever
September 01, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.